[
  {
    "ts": null,
    "headline": "Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025",
    "summary": "FOSTER CITY, Calif., April 10, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2025 financial results and guidance will be released on Thursday, April 24, 2025 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s first quarter 2025 financial results and provide a business update.",
    "url": "https://finnhub.io/api/news?id=a4eb71afb6151cf896232167339b4a3baa6dd8238817bb0ec501187e10582b4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744315500,
      "headline": "Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025",
      "id": 133873351,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "FOSTER CITY, Calif., April 10, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2025 financial results and guidance will be released on Thursday, April 24, 2025 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s first quarter 2025 financial results and provide a business update.",
      "url": "https://finnhub.io/api/news?id=a4eb71afb6151cf896232167339b4a3baa6dd8238817bb0ec501187e10582b4e"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=90aca6d82f7d71ab87afc1bda37e466f64719e7d8bff93591eff82867939fac4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744302960,
      "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
      "id": 133888116,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=90aca6d82f7d71ab87afc1bda37e466f64719e7d8bff93591eff82867939fac4"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences : First Quarter 2025 Estimated Acquired IPR&D",
    "summary": "Estimated First Quarter 2025 Acquired In-Process Research and Development Charges For the first quarter of 2025, Gilead currently expects $253.4M in acquired IPR&D expenses,...",
    "url": "https://finnhub.io/api/news?id=e8ae12ad9f1a73bf8689e12c6b4b2c841bc67ab7fb494d6a063283c96a39505f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744302135,
      "headline": "Gilead Sciences : First Quarter 2025 Estimated Acquired IPR&D",
      "id": 133869274,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Estimated First Quarter 2025 Acquired In-Process Research and Development Charges For the first quarter of 2025, Gilead currently expects $253.4M in acquired IPR&D expenses,...",
      "url": "https://finnhub.io/api/news?id=e8ae12ad9f1a73bf8689e12c6b4b2c841bc67ab7fb494d6a063283c96a39505f"
    }
  },
  {
    "ts": null,
    "headline": "PatientView Ranks Gilead \"Best\" at ESG",
    "summary": "NORTHAMPTON, MA / ACCESS Newswire / April 10, 2025 / At Gilead, putting people first is central to all we do. That's why we're proud to be recognized as a responsible company by patient advocacy groups representing more than 70 countries. In a new ...",
    "url": "https://finnhub.io/api/news?id=916141ed4de1becac4e86f91bf4ce1f25fd88368ef56f2cd62d5b3114a1d0646",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744289400,
      "headline": "PatientView Ranks Gilead \"Best\" at ESG",
      "id": 133844414,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "NORTHAMPTON, MA / ACCESS Newswire / April 10, 2025 / At Gilead, putting people first is central to all we do. That's why we're proud to be recognized as a responsible company by patient advocacy groups representing more than 70 countries. In a new ...",
      "url": "https://finnhub.io/api/news?id=916141ed4de1becac4e86f91bf4ce1f25fd88368ef56f2cd62d5b3114a1d0646"
    }
  }
]